More than 25,000 P!NK fans came to Petco Park earlier this month for the 2026 Concert for Cures, raising $8.25 million for local philanthropic organization Curebound, it was announced Friday.
May’s funding brings the total raised across the four-year history of the concert series to more than $28 million for cancer research.
Many of the fans in attendance were cancer survivors, including 1,500 who were invited to attend by the Manchester Family Foundation.
The annual Concert for Cures is Curebound’s largest fundraiser, helping the organization raise and invest strategic funding for cancer research. Previous headliners of the show include Elton John at Petco, Alicia Keys with the San Diego Symphony Orchestra and Ed Sheeran performing to sold- out crowds at the Rady Shell at Jacobs Park.
P!NK was the 2026 featured artist. She debuted in 2000, and has since built a career defined by “fearless honesty, unforgettable live shows and a refusal to fit a mold.” Across nine studio albums and a greatest hits collection, she’s sold more than 60 million albums worldwide and earned 15 Top 10 hits on the Billboard Hot 100 (including four No. 1s). Her work has been recognized with three Grammy Awards (and 21 nominations).
She is also a nominee for the 2026 Rock & Roll Hall of Fame.
“I want to give a shoutout to Curebound because you are doing some of the most important work that there is to do,” P!NK said on stage. “Cancer sucks and I am just very grateful to be of use, and I am very grateful to be here with all of you, and I am just very grateful.”
Since launching in 2022, Concert for Cures has brought in more than 60,000 people to raise funds for the nonprofit.
“Every person in this stadium is helping fund the science that will define how we prevent, detect and treat cancer for the next generation,” said Robin Toft, CEO of Curebound. “At a time when national research funding remains uncertain, what we are doing here at Curebound matters more than ever.”
Curebound has awarded $51.5 million in cancer research grants, supporting 170 studies across 23 types of adult and pediatric cancers. That investment has led to 30 expanded clinical trials reaching 1,864 patients and generated $161 million in follow-on funding, a statement from the organization read.
“Every research breakthrough gives families more options, every option gives them more time, and more time offers more hope,” said Curebound Board Chair Rick Valencia, who co-chaired the concert organizing committee with his daughter, Aubrey Salvati. “That’s how Curebound measures success, not just in dollars raised, but in the moments families get to share together.”